Cargando…

Neoantigen Targetability in Progressive Advanced Melanoma

PURPOSE: The availability of (neo)antigens and the infiltration of tumors by (neo)antigen-specific T cells are crucial factors in cancer immunotherapy. In this study, we aimed to investigate the targetability of (neo)antigens in advanced progessive melanoma and explore the potential for continued T-...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Bulk, Jitske, Verdegaal, Els M.E., van der Ploeg, Manon, Visser, Marten, Nunes, Joana B., de Ru, Arnoud H., Tjokrodirijo, Rayman T.N., Ijsselsteijn, Marieke E., Janssen, Natasja I., van der Breggen, Ruud, de Bruin, Linda, de Kok, Pita, Janssen, George M.C., Ruano, Dina, Kapiteijn, Ellen H.W., van Veelen, Peter A., de Miranda, Noel F.C.C., van der Burg, Sjoerd H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Translational Cancer Mechanisms and Therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570682/ https://www.ncbi.nlm.nih.gov/pubmed/37540567 http://dx.doi.org/10.1158/1078-0432.CCR-23-1106

Ejemplares similares

Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4
por: van den Bulk, Jitske, et al.
Publicado: (2019)

CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden
por: van den Bulk, Jitske, et al.
Publicado: (2023)

Cancer immunotherapy: broadening the scope of targetable tumours
por: van den Bulk, Jitske, et al.
Publicado: (2018)

Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression
por: van den Bulk, Jitske, et al.
Publicado: (2021)

Identification of non-mutated neoantigens presented by TAP-deficient tumors
por: Marijt, Koen A., et al.
Publicado: (2018)

Tumor-Infiltrating T Cells Can Be Expanded Successfully from Primary Uveal Melanoma after Separation from Their Tumor Environment
por: Gezgin, Gülçin, et al.
Publicado: (2022)

Oxonium Ion Guided Analysis of Quantitative Proteomics Data Reveals Site-Specific O-Glycosylation of Anterior Gradient Protein 2 (AGR2)
por: Pirro, Martina, et al.
Publicado: (2021)

N-Glycoproteins Have a Major Role in MGL Binding to Colorectal Cancer Cell Lines: Associations with Overall Proteome Diversity
por: Pirro, Martina, et al.
Publicado: (2020)

A 40-Marker Panel for High Dimensional Characterization of Cancer Immune Microenvironments by Imaging Mass Cytometry
por: Ijsselsteijn, Marieke E., et al.
Publicado: (2019)

Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines
por: van den Ende, Thomas C., et al.
Publicado: (2020)

The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy
por: Verdegaal, Els M. E., et al.
Publicado: (2017)

γδ T cells are effectors of immunotherapy in cancers with HLA class I defects
por: de Vries, Natasja L., et al.
Publicado: (2023)

Low-dose interferon-alpha preconditioning and adoptive cell therapy in patients with metastatic melanoma refractory to standard (immune) therapies: a phase I/II study
por: Verdegaal, Els, et al.
Publicado: (2020)

Uveal Versus Cutaneous Melanoma; Same Origin, Very Distinct Tumor Types
por: van der Kooij, Monique K., et al.
Publicado: (2019)

Identification of a neo-epitope dominating endogenous CD8 T cell responses to MC-38 colorectal cancer
por: Hos, Brett J., et al.
Publicado: (2019)

Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains
por: Abendstein, Leoni, et al.
Publicado: (2023)

Phase I/II study protocol to assess safety and efficacy of adoptive cell therapy with anti-PD-1 plus low-dose pegylated-interferon-alpha in patients with metastatic melanoma refractory to standard of care treatments: the ACTME trial
por: van der Kooij, Monique K, et al.
Publicado: (2020)

High-dimensional cytometric analysis of colorectal cancer reveals novel mediators of antitumour immunity
por: de Vries, Natasja L, et al.
Publicado: (2020)

Fc gamma receptor IIIb binding of individual antibody proteoforms resolved by affinity chromatography–mass spectrometry
por: Lippold, Steffen, et al.
Publicado: (2021)

The identification of the anthracycline aclarubicin as an effective cytotoxic agent for pancreatic cancer
por: Brouwer, Thomas P., et al.
Publicado: (2022)

Revisiting immune escape in colorectal cancer in the era of immunotherapy
por: Ijsselsteijn, Marieke Erica, et al.
Publicado: (2019)

IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma
por: Melief, Sara M., et al.
Publicado: (2017)

Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha
por: Verdegaal, Els M. E., et al.
Publicado: (2011)

A Paradoxical Role for Regulatory T Cells in the Tumor Microenvironment of Pancreatic Cancer
por: Brouwer, Thomas, et al.
Publicado: (2022)

Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review
por: Baltussen, Joosje C., et al.
Publicado: (2021)

Immunologic aspect of ovarian cancer and p53 as tumor antigen
por: Nijman, HW, et al.
Publicado: (2005)

Quantitative proteomics of small numbers of closely-related cells: Selection of the optimal method for a clinical setting
por: van der Pan, Kyra, et al.
Publicado: (2022)

Targeting of the Cancer-Associated Fibroblast—T-Cell Axis in Solid Malignancies
por: Harryvan, Tom J., et al.
Publicado: (2019)

Imaging mass cytometry reveals the prominent role of myeloid cells at the maternal-fetal interface
por: Krop, Juliette, et al.
Publicado: (2022)

Genetic adaptation of bacteria to halogenated aliphatic compounds.
por: Janssen, D B, et al.
Publicado: (1995)

The nonpolymorphic MHC Qa-1(b) mediates CD8(+) T cell surveillance of antigen-processing defects
por: Oliveira, Cláudia C., et al.
Publicado: (2010)

The nonpolymorphic MHC Qa-1(b) mediates CD8(+) T cell surveillance of antigen-processing defects
por: Oliveira, Cláudia C., et al.
Publicado: (2010)

An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML
por: van der Lee, Dyantha I., et al.
Publicado: (2021)

Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer
por: Verdegaal, Els M E, et al.
Publicado: (2023)

Apparent Lack of BRAF(V600E) Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8(+) T Cells in Langerhans Cell Histiocytosis
por: Kemps, Paul G., et al.
Publicado: (2020)

Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S
por: Harryvan, Tom J, et al.
Publicado: (2022)

Immunotherapy of Human Papilloma Virus Induced Disease
por: van der Burg, Sjoerd H
Publicado: (2012)

Epigenetics Identifier screens reveal regulators of chromatin acylation and limited specificity of acylation antibodies
por: Kollenstart, Leonie, et al.
Publicado: (2021)

Synergy between chemotherapy and cancer vaccination
por: van der Sluis, Tetje C., et al.
Publicado: (2015)

Transcriptomic and immunophenotypic profiling reveals molecular and immunological hallmarks of colorectal cancer tumourigenesis
por: Roelands, Jessica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7oda0tpgle8u8f0v1968rslbqh